Similar articles

• Red blood cell distribution width and 1-year mortality in acute heart failure.

  van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, Januzzi JL Jr. van Kimmenade RR, et al. Eur J Heart Fail. 2010 Feb;12(2):129-36. doi: 10.1093/eurjhf/hfp179. Epub 2009 Dec 20. Eur J Heart Fail. 2010. PMID: 20026456
• Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study.

  Baggish AL, van Kimmenade R, Bayes-Genis A, Davis M, Lainchbury JG, Frampton C, Pinto Y, Richards MA, Januzzi JL. Baggish AL, et al. Clin Chim Acta. 2007 Jun;381(2):145-50. doi: 10.1016/j.cca.2007.03.010. Epub 2007 Mar 19. Clin Chim Acta. 2007. PMID: 17445789
• Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.

  Felker GM, Hasselblad V, Hernandez AF, O'Connor CM. Felker GM, et al. Am Heart J. 2009 Sep;158(3):422-30. doi: 10.1016/j.ahj.2009.06.018. Epub 2009 Jul 9. Am Heart J. 2009. PMID: 19699866
• [BNP or NT-proBNP should be analyzed in suspected heart failure. Guidelines for analysis and interpretation].

  Jernberg T, Boman K, James S, Lindahl B, Stridsberg M, Swedberg K, Venge P. Jernberg T, et al. Lakartidningen. 2006 Apr 26-May 2;103(17):1289-92, 1295. Lakartidningen. 2006. PMID: 16708856 Review. Swedish. No abstract available.
• [Biomarkers in heart failure: are they clinically useful?].

  Kempf T, Wollert KC. Kempf T, et al. Dtsch Med Wochenschr. 2009 Apr;134(15):740-6. doi: 10.1055/s-0029-1220224. Epub 2009 Apr 1. Dtsch Med Wochenschr. 2009. PMID: 19340752 Review. German. No abstract available.